347 related articles for article (PubMed ID: 30187864)
41. Anti-Inflammatory Dose Doxycycline Plus Adapalene 0.3% and Benzoyl Peroxide 2.5% Gel for Severe Acne.
Kircik LH
J Drugs Dermatol; 2019 Sep; 18(9):924-927. PubMed ID: 31524349
[TBL] [Abstract][Full Text] [Related]
42. Ceramide-Containing Adjunctive Skin Care for Skin Barrier Restoration During Acne Vulgaris Treatment.
Draelos ZD; Baalbaki N; Colon G; Dreno B
J Drugs Dermatol; 2023 Jun; 22(6):554-558. PubMed ID: 37276158
[TBL] [Abstract][Full Text] [Related]
43. A randomized controlled double-blinded split-face prospective clinical trial to assess the efficacy, safety, and tolerability of a novel 3-step routine compared to benzoyl peroxide for the treatment of mild to moderate acne vulgaris.
Gern A; Walter J; Xu S; Vakharia PP
Arch Dermatol Res; 2024 May; 316(6):230. PubMed ID: 38787441
[TBL] [Abstract][Full Text] [Related]
44. Synergistic efficacy of adapalene 0.1%-benzoyl peroxide 2.5% in the treatment of 3855 acne vulgaris patients.
Tan J; Gollnick HP; Loesche C; Ma YM; Gold LS
J Dermatolog Treat; 2011 Aug; 22(4):197-205. PubMed ID: 20666678
[TBL] [Abstract][Full Text] [Related]
45. Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.
Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Chavda R; Kerrouche N; Tan J
Am J Clin Dermatol; 2019 Oct; 20(5):725-732. PubMed ID: 31209851
[TBL] [Abstract][Full Text] [Related]
46. Tolerability and irritation potential of four topical acne regimens in healthy subjects.
Grove G; Zerweck C; Gwazdauskas J
J Drugs Dermatol; 2013 Jun; 12(6):644-9. PubMed ID: 23839180
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
Thiboutot D; Arsonnaud S; Soto P
J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220
[TBL] [Abstract][Full Text] [Related]
48. Effect of adapalene 0.1%/benzoyl peroxide 2.5% topical gel on quality of life and treatment adherence during long-term application in patients with predominantly moderate acne with or without concomitant medication - additional results from the non-interventional cohort study ELANG.
Gollnick HP; Friedrich M; Peschen M; Pettker R; Pier A; Streit V; Jöstingmeyer P; Porombka D; Rojo Pulido I; Jäckel A
J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 4():23-9. PubMed ID: 26059731
[TBL] [Abstract][Full Text] [Related]
49. Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study.
Fleischer AB; Shalita A; Eichenfield LF; Abramovits W; Lucky A; Garrett S;
J Drugs Dermatol; 2010 Jan; 9(1):33-40. PubMed ID: 20120423
[TBL] [Abstract][Full Text] [Related]
50. Open-label, randomized, multicenter, phase III study to evaluate the safety and efficacy of benzoyl peroxide gel in long-term use in patients with acne vulgaris: A secondary publication.
Kawashima M; Nagare T; Katsuramaki T
J Dermatol; 2017 Jun; 44(6):635-643. PubMed ID: 28150367
[TBL] [Abstract][Full Text] [Related]
51. Digital videography assessment of patients' experiences using adapalene-benzoyl peroxide gel in the treatment of acne vulgaris.
Feldman SR; Fried RG; Herndon JH; Johnson L; Preston N; Gottschalk RW; Caveney SW
J Drugs Dermatol; 2012 Aug; 11(8):919-25. PubMed ID: 22859236
[TBL] [Abstract][Full Text] [Related]
52. A multicentre, randomized, single-blind, parallel-group study comparing the efficacy and tolerability of benzoyl peroxide 3%/clindamycin 1% with azelaic acid 20% in the topical treatment of mild-to-moderate acne vulgaris.
Schaller M; Sebastian M; Ress C; Seidel D; Hennig M
J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):966-73. PubMed ID: 26915831
[TBL] [Abstract][Full Text] [Related]
53. Is benzoyl peroxide 3% topical gel effective and safe in the treatment of acne vulgaris in Japanese patients? A multicenter, randomized, double-blind, vehicle-controlled, parallel-group study.
Kawashima M; Hashimoto H; Alio Sáenz AB; Ono M; Yamada M
J Dermatol; 2014 Sep; 41(9):795-801. PubMed ID: 25132461
[TBL] [Abstract][Full Text] [Related]
54. Adapalene 0.1% and benzoyl peroxide 2.5%: a novel combination for treatment of acne vulgaris.
Tan JK
Skin Therapy Lett; 2009; 14(6):4-5. PubMed ID: 19609474
[TBL] [Abstract][Full Text] [Related]
55. Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study.
Kircik L; Green L; Thiboutot D; Tanghetti E; Wilson D; Dhawan S; Parr L
J Drugs Dermatol; 2009 Sep; 8(9):812-8. PubMed ID: 19746673
[TBL] [Abstract][Full Text] [Related]
56. Community study of fixed-combination adapalene 0.1% and benzoyl peroxide 2.5% in acne.
Troielli PA; Asis B; Bermejo A; Bittar M; Cabrera H; Castro C; Chouela E; Cordero A; Dobrinin R; Escobar S; Fortino M; Galimberti D; Galimberti G; Giovo ME; Gomez B; Gras Mdel C; Ibarra M; Kizlansky V; Chabbert PM; Ramonda S;
Skinmed; 2010; 8(1):17-22. PubMed ID: 20839420
[TBL] [Abstract][Full Text] [Related]
57. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.
Gold LS; Cruz A; Eichenfield L; Tan J; Jorizzo J; Kerrouche N; Dhuin JC
Cutis; 2010 Feb; 85(2):94-104. PubMed ID: 20349684
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of ceramides and niacinamide-containing moisturizer versus hydrophilic cream in combination with topical anti-acne treatment in mild to moderate acne vulgaris: A split face, double-blinded, randomized controlled trial.
Tempark T; Shem A; Lueangarun S
J Cosmet Dermatol; 2024 May; 23(5):1758-1765. PubMed ID: 38299457
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and safety of 2% supramolecular salicylic acid compared with 5% benzoyl peroxide/0.1% adapalene in the acne treatment: a randomized, split-face, open-label, single-center study.
Zheng Y; Yin S; Xia Y; Chen J; Ye C; Zeng Q; Lai W
Cutan Ocul Toxicol; 2019 Mar; 38(1):48-54. PubMed ID: 30173582
[TBL] [Abstract][Full Text] [Related]
60. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
Callender VD
J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
